Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure with reduced ejection fraction
Michelle Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Zhipeng Cao, Yuqing Jia, Bao-Li Zhu
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1820-1820
Open Access | Times Cited: 281
Endothelin: 30 Years From Discovery to Therapy
Matthias Barton, Masashi Yanagisawa
Hypertension (2019) Vol. 74, Iss. 6, pp. 1232-1265
Open Access | Times Cited: 246
Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention
Anchit Bhagat, Eugenie S. Kleinerman
Advances in experimental medicine and biology (2020), pp. 181-192
Closed Access | Times Cited: 158
Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study
Patrik Bächtiger, Camille F Petri, Francesca E Scott, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 2, pp. e117-e125
Open Access | Times Cited: 99
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
Julia Ritterhoff, Rong Tian
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 812-829
Closed Access | Times Cited: 90
Structure-based design of non-hypertrophic apelin receptor modulator
Weiwei Wang, Su‐Yu Ji, W. Zhang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1460-1475.e20
Closed Access | Times Cited: 17
Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing
Olya Mastikhina, Byeong-Ui Moon, Kenneth Williams, et al.
Biomaterials (2019) Vol. 233, pp. 119741-119741
Closed Access | Times Cited: 141
Complexity of TNF-α Signaling in Heart Disease
Filip Rolski, Przemysław Błyszczuk
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3267-3267
Open Access | Times Cited: 120
SERCA2a: a key protein in the Ca2+ cycle of the heart failure
Zhihao Liu, Jingyu Ni, Lan Li, et al.
Heart Failure Reviews (2019) Vol. 25, Iss. 3, pp. 523-535
Closed Access | Times Cited: 118
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers
Josip A. Borovac, Domenico D’Amario, Joško Božić, et al.
World Journal of Cardiology (2020) Vol. 12, Iss. 8, pp. 373-408
Open Access | Times Cited: 109
Precision wearable accelerometer contact microphones for longitudinal monitoring of mechano-acoustic cardiopulmonary signals
Pranav Gupta, Mohammad J. Moghimi, Yaesuk Jeong, et al.
npj Digital Medicine (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 91
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
Anita A. Pinar, Tara Scott, Brooke M. Huuskes, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107511-107511
Closed Access | Times Cited: 77
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
Zhiwei Li, Hongmei Zhao, Jing Wang
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 60
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 55
Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context
Mpiko Ntsekhe, Jason V. Baker
Circulation (2022) Vol. 147, Iss. 1, pp. 83-100
Open Access | Times Cited: 44
Reverse re-modelling chronic heart failure by reinstating heart rate variability
Julia Shanks, Yonis Abukar, Nigel Lever, et al.
Basic Research in Cardiology (2022) Vol. 117, Iss. 1
Open Access | Times Cited: 39
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Jacob Joseph, Chang Liu, Qin Hui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periosti
Xie Wei, Jing Gan, Xiaodong Zhou, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1269-1286.e9
Closed Access | Times Cited: 13
Biorobotic hybrid heart as a benchtop cardiac mitral valve simulator
Clara Park, Manisha Singh, Mossab Y. Saeed, et al.
Device (2024) Vol. 2, Iss. 1, pp. 100217-100217
Open Access | Times Cited: 9
Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure
Yuqing Tian, Jiefu Yang, Ming Lan, et al.
Aging (2020) Vol. 12, Iss. 24, pp. 26221-26235
Open Access | Times Cited: 55
Heart failure, frailty, and pre-frailty: A systematic review and meta-analysis of observational studies
Alessandra Marengoni, Alberto Zucchelli, Davide Liborio Vetrano, et al.
International Journal of Cardiology (2020) Vol. 316, pp. 161-171
Closed Access | Times Cited: 50
Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway
Linhao Xu, Daqiang He, Yirong Wu, et al.
Phytomedicine (2022) Vol. 107, pp. 154471-154471
Closed Access | Times Cited: 33
Defining the Sarcomeric Proteoform Landscape in Ischemic Cardiomyopathy by Top-Down Proteomics
Emily A. Chapman, Timothy J. Aballo, Jake A. Melby, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 3, pp. 931-941
Closed Access | Times Cited: 20
Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention
Tienan Sun, Xin Huang, Biyang Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
High intensity interval training vs. moderate intensity continuous training on aerobic capacity and functional capacity in patients with heart failure: a systematic review and meta-analysis
changran yang, Lizhuang Zhang, Yu Cheng, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top